Stimulation of the ADRB3 adrenergic receptor induces relaxation of human placental arteries: Influence of preeclampsia

Biology of Reproduction

Volumn 74, Issue 1, 2006, Pages 209-216

  Rouget, C ^a,b,c   Barthez, O ^a   Goirand, F ^a   Leroy, M J ^c   Breuiller Fouche M ^c   Rakotoniaina, Z ^a   Guerard P ^a   Morcillo, E J ^d   Advenier, C ^b   Sagot, P ^e   Cabrol, D ^c,f   Dumas, M ^a   Bardou, M ^a,b  

^a UNIVERSITÉ DE BOURGOGNE   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c INSERM   (France)

^d UNIVERSITY OF VALENCIA   (Spain)

^e HÔPITAL DU BOCAGE   (France)

^f Port Royal Cochin Hospital ^*  (France)

Author keywords

Catecholamines; Cyclic adenosine monophosphate; Cyclic guanosine monophosphate; Placenta; Pregnancy

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR; CYCLIC AMP; ISOPRENALINE; N [(7 METHOXY 1,2,3,4 TETRAHYDRONAPHTHALEN 2 YL)METHYL] 2 HYDROXY 2 (3 CHLOROPHENYL)ETHANAMINE; PROPRANOLOL; SALBUTAMOL; SR 59119A; UNCLASSIFIED DRUG;

ADRB2 GENE; ADRB3 GENE; ARTERY; ARTICLE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; NEWBORN MORBIDITY; NEWBORN MORTALITY; PLACENTA; PREECLAMPSIA; PREGNANCY COMPLICATION; PRIORITY JOURNAL; RECEPTOR GENE; RECEPTOR UPREGULATION; WESTERN BLOTTING;

ADRENERGIC BETA-AGONISTS; ALBUTEROL; ARTERIES; ETHANOLAMINES; FEMALE; HUMANS; ISOPROTERENOL; NUCLEOTIDES, CYCLIC; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; RECEPTORS, ADRENERGIC, BETA-2; RECEPTORS, ADRENERGIC, BETA-3; TETRAHYDRONAPHTHALENES; VASODILATION;

EID: 30344439829     PISSN: 00063363     EISSN: None     Source Type: Journal    
DOI: 10.1095/biolreprod.105.043695     Document Type: Article

References (45)

1. Lee W, O'Connell CM, Baskett TF. Maternal and perinatal outcomes of eclampsia: Nova Scotia, 1981-2000. J Obstet Gynaecol Can 2004; 26: 119-123.
2. Haukkamaa L, Salminen M, Laivuori H, Leinonen H, Hiilesmaa V, Kaaja R. Risk for subsequent coronary artery disease after preeclampsia. Am J Cardiol 2004; 93:805-808.
3. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000; 183:S1-S22.
4. Granger JP, Alexander BT, Llinas MT, Bennett WA, Khalil RA. Pathophysiology of preeclampsia: linking placental ischemia/hypoxia with microvascular dysfunction. Microcirculation 2002; 9:147-160.
5. Bertrand C, Duperron L, St-Louis J. Umbilical and placental vessels: modifications of their mechanical properties in preeclampsia. Am J Obstet Gynecol 1993; 168:1537-1546.
6. Sibai B, Dekker G, Kupfermine M. Preeclampsia. Lancet 2005; 365:785-799.
7. Levine RJ, Thadhani R, Qian C, Lam C, Lim KH, Yu KF, Blink AL, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA. Urinary placental growth factor and risk of preeclampsia. JAMA 2005; 293:77-85.
8. Thadhani R, Mutter WP, Wolf M, Levine RJ, Taylor RN, Sukhatme VP, Ecker J, Karumanchi SA. First-trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia. J Clin Endocrinol Metab 2004; 89:770-775.
9. Manyonda IT, Slater DM, Fenske C, Hole D, Choy MY, Wilson C. A role for noradrenaline in preeclampsia: towards a unifying hypothesis for the pathophysiology. Br J Obstet Gynaecol 1998; 105:641-648.
10. 2-adrenoceptor signal system in preeclampsia. Br J Obstet Gynaecol 2000; 107:116-121.
11. 3-adrenergic receptor. Science 1989; 245:1118-1121.
12. 3-adrenergic receptor gene. Mol Pharmacol 1993; 44:264-270.
13. Strosberg AD. Structure, function, and regulation of adrenergic receptors. Protein Sci 1993; 2:1198-1209.
14. Arch JR, Ainsworth AT, Cawthorne MA, Piercy V, Sennitt MV, Thody VE, Wilson C, Wilson S. Atypical β-adrenoceptor on brown adipocytes as target for anti-obesity drugs. Nature 1984; 309:163-165.
15. 3- adrenoceptor-mediated effect. Eur J Pharmacol 1998; 353:281-287.
16. 3-adrenoceptor in human near-term myometrium. Br J Pharmacol 2000; 130:1960-1966.
17. 3-Adrenoceptor is the predominant β-adrenoceptor subtype in human myometrium and its expression is upregulated in pregnancy. J Clin Endocrinol Metab 2005; 90: 1644-1650.
18. 3-Adrenoceptor-mediated increase in cutaneous blood flow in the dog. J Pharmacol Exp Ther 1994; 268:1444-1451.
19. 3-Adrenoceptor stimulation induces vasorelaxation mediated essentially by endothelium-derived nitric oxide in rat thoracic aorta. Br J Pharmacol 1999; 128:69-76.
20. 3-adrenergic receptor. Annu Rev Pharmacol Toxicol 1997; 37:421-450.
21. 2- adrenoceptor is resistant to desensitization after sustained agonist stimulation. Br J Pharmacol 2004; 141:831-841.
22. 3- adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle. J Clin Invest 1998; 102:1377-1384.
23. 3-adrenoreceptor agonists: human myometrial selectivity and effects on umbilical artery tone. Am J Obstet Gynecol 2002; 187:641-647.
24. Roberts SJ, Russell FD, Molenaar P, Summers RJ. Characterization and localization of atypical β-adrenoceptors in rat ileum. Br J Pharmacol 1995; 116:2549-2556.
25. Mehats C, Tanguy G, Dallot E, Robert B, Rebourcet R, Ferre F, Leroy MJ. Selective upregulation of phosphodiesterase-4 cyclic adenosine 3′,5′-monophosphate (cAMP)-specific phosphodiesterase variants by elevated cAMP content in human myometrial cells in culture. Endocrinology 1999; 140:3228-3237.
26. Bardou M, Cortijo J, Loustalot C, Taylor S, Perales-Marin A, Mercier FJ, Dumas M, Deneux-Tharaux C, Frydman R, Morcillo EJ, Advenier C. Pharmacological and biochemical study on the effects of selective phosphodiesterase inhibitors on human term myometrium. Naunyn Schmiedebergs Arch Pharmacol 1999; 360:457-463.
27. Wareing M, Crocker IP, Warren AY, Taggart MJ, Baker PN. Characterization of small arteries isolated from the human placental chorionic plate. Placenta 2002; 23:400-409.
28. Resch BE, Ducza E, Gaspar R, Falkay G. Role of adrenergic receptor subtypes in the control of human placental blood vessels. Mol Reprod Dev 2003; 66:166-171.
29. Leroy MJ, Cedrin I, Breuiller M, Giovagrandi Y, Ferre F. Correlation between selective inhibition of the cyclic nucleotide phosphodiesterases and the contractile activity in human pregnant myometrium near term. Biochem Pharmacol 1989; 38:9-15.
30. Tamaoki J, Tagaya E, Isono K, Nagai A. Atypical adrenoceptor-mediated relaxation of canine pulmonary artery through a cAMP-dependent pathway. Biochem Biophys Res Commun 1998; 248:722-727.
31. 3-adrenoceptors mediate vasorelaxation of human coronary microarteries through nitric oxide and endothelium-dependent hyperpolarization. Circulation 2004; 110:948-954.
32. 3-Adrenoceptor in rat aorta: molecular and biochemical characterization and signaling pathway. Br J Pharmacol 2002; 137:153-161.
33. Roberts JM, Lain KY. Recent insights into the pathogenesis of preeclampsia. Placenta 2002; 23:359-372.
34. Groop L, Orho-Melander M. The dysmetabolic syndrome. J Intern Med 2001; 250:105-120.
35. 3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns. N Engl J Med 1995; 333:348-351.
36. 3-adrenergic receptor is not increased in women with preeclampsia. Am J Obstet Gynecol 2004; 190:779-783.
37. Lecrivain JL, Cohen-Tannoudji J, Robin MT, Coudouel N, Legrand C, Maltier JP. Molecular mechanisms of adenylyl cyclase desensitization in pregnant rat myometrium following in vivo administration of the β-adrenergic agonist, isoproterenol. Biol Reprod 1998; 59:45-52.
38. Engelhardt S, Zieger W, Kassubek J, Michel MC, Lohse MJ, Brodde OE. Tocolytic therapy with fenoterol induces selective downregulation of β-adrenergic receptors in human myometrium. J Clin Endocrinol Metab 1997; 82:1235-1242.
39. Litime MH, Pointis G, Breuiller M, Cabrol D, Ferre F. Disappearance of β-adrenergic response of human myometrial adenylate cyclase at the end of pregnancy. J Clin Endocrinol Metab 1989; 69:1-6.
40. Inayatulla A, Chemtob S, Nuwayhid B, Varma DR. Responses of placental arteries from normotensive and preeclamptic women to endogenous vasoactive agents. Am J Obstet Gynecol 1993; 168:869-874.
41. Ong SS, Crocker IP, Warren AY, Baker PN. Functional characteristics of chorionic plate placental arteries from normal pregnant women and women with preeclampsia. Hypertens Pregnancy 2002; 21:175-183.
42. 125I]- iodocyanopindolol binding. Gynecol Obstet Invest 1987; 24:28-37.
43. Mostello D, Catlin TK, Roman L, Holcomb WL Jr, Leet T. Preeclampsia in the parous woman: who is at risk? Am J Obstet Gynecol 2002; 187: 425-429.
44. 3- adrenergic receptor agonist, on energy expenditure and body composition in obese men. Am J Clin Nutr 2002; 76:780-788.
45. Hakak Y, Shrestha D, Goegel MC, Behan DP, Chalmers DT. Global analysis of G protein-coupled receptor signaling in human tissues. FEBS Lett 2003; 550:11-17.